lymphomas < lymphoproliferative < lymphotropic

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by lymphoproliferative

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
000248 (2019)	Koji Nanmoku [Japon] ; Takahiro Shinzato [Japon] ; Taro Kubo [Japon] ; Toshihiro Shimizu [Japon] ; Takashi Yagisawa [Japon]	Remission of Epstein-Barr virus-positive post-transplant lymphoproliferative disorder by conversion to everolimus in a kidney transplant recipient.
000521 (2018)	Lorena Castillo-Eraso [Espagne] ; Edoardo Melilli ; Carmen Cabre ; Anna Manonelles ; Julieta Landeyro ; Oriol Bestard ; Josep M. Cruzado ; Alberto Martinez-Vea	Posttransplant Lymphoproliferative Disease and Inhibitors of Mammalian Target of Rapamycin: When a Quick Look Back Can Change the Perspective.
000564 (2018)	J. Rego Silva [Portugal] ; R A Macau [Portugal] ; H. Oliveira Coelho [Portugal] ; F. Camelo [Portugal] ; P. Cruz [Portugal] ; A. Mateus [Portugal] ; A. Oliveira [Portugal] ; C. Oliveira [Portugal] ; A. Ramos [Portugal]	Late-Onset Post-transplantation Central Nervous System Lymphoproliferative Disorder: Case Report.
000893 (2017)	Erica Franceschini [Italie] ; Jessica Plessi [Italie] ; Stefano Zona [Italie] ; Antonella Santoro [Italie] ; Margherita Digaetano [Italie] ; Francesco Fontana [Italie] ; Gaetano Alfano [Italie] ; Giovanni Guaraldi [Italie] ; Patrizia Comoli [Italie] ; Francesca Facchini [Italie] ; Leonardo Potenza [Italie] ; William Gennari [Italie] ; Mauro Codeluppi [Italie] ; Mario Luppi [Italie] ; Gianni Cappelli [Italie] ; Inge C. Gyssens ; Cristina Mussini [Italie]	Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation: A Single-Center, 10-Year Observational Cohort Study.
000D22 (2015)	R. San-Juan [Espagne] ; O. Manuel [Suisse] ; H H Hirsch [Suisse] ; M. Fernández-Ruiz [Espagne] ; F. L Pez-Medrano [Espagne] ; P. Comoli [Italie] ; S. Caillard [France] ; P. Grossi [Italie] ; J M Aguado [Espagne]	Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey.
000F13 (2014)	Francesco Ceppi [Canada] ; Michel Duval ; Pierre Teira ; Roxane Therrien ; Philippe Ovetchkine ; Brigitte Mallette ; Henrique Bittencourt	Calcineurin inhibitor-free graft-versus-host disease prophylaxis with sirolimus and mycophenolate mofetil in a second allogeneic stem cell transplantation for engraftment failure and rituximab-refractory Epstein-Barr virus-induced posttransplant lymphoproliferative disease.
000F14 (2014)	Eylem Akar Zkan [Turquie] ; B Handan Özdemir ; Ayd Ncan Akdur ; E Ebru Deniz ; Mehmet Haberal	Burkitt lymphoma after transplant: an aggressive lymphoproliferative disease.
001196 (2012)	Beverly P. Nelson [États-Unis] ; Kristy L. Wolniak ; Andrew Evens ; Anjen Chenn ; John Maddalozzo ; Maria Proytcheva	Early posttransplant lymphoproliferative disease: clinicopathologic features and correlation with mTOR signaling pathway activation.
001237 (2011)	Mohamed Mongi Bacha [Tunisie] ; Ezzeddine Abderrahim ; Mondher Ounissi ; Dalel Chaouech ; Mejda Cherif ; Sami Turki ; Hatem Rajhi ; Nadia Znaidi ; Abdessalem Bahloul ; Sonia Trabelsi ; Samira Khaled ; Taïeb Ben Abdallah ; Hedi Ben Maïz ; Adel Kheder	[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation].
001261 (2011)	Nishitha Reddy [États-Unis] ; Katayoun Rezvani ; A John Barrett ; Bipin N. Savani	Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.
001323 (2011)	Sarah E. Gibson [États-Unis] ; Steven H. Swerdlow ; Fiona E. Craig ; Urvashi Surti ; James R. Cook ; Michael A. Nalesnik ; Chris Lowe ; Katrina M. Wood ; Chris M. Bacon	EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder?
001557 (2008)	Shernan G. Holtan ; Luis F. Porrata ; Joseph P. Colgan ; Clive S. Zent ; Thomas M. Habermann ; Svetomir N. Markovic	mTOR inhibitor monotherapy is insufficient to suppress viremia and disease progression in Epstein-Barr virus-driven lymphoproliferative disorders (EBV-LPD).
001614 (2008)	D D Henry [États-Unis] ; S P Hunger ; R C Braylan ; V R Dharnidharka	Low viral load post-transplant lymphoproliferative disease localized within the tongue.
001768 (2006)	Alison J. Bruce [États-Unis] ; Antonio Subtil ; Roy S. Rogers ; Luis A. Castro	Monomorphic Epstein-Barr virus (EBV)-associated large B-cell posttransplant lymphoproliferative disorder presenting as a tongue ulcer in a pancreatic transplant patient.
001938 (2003)	Vasundhara Ganne [États-Unis] ; Nauman Siddiqi ; Bal Kamaplath ; Chung-Che Chang ; Eric P. Cohen ; Barbara A. Bresnahan ; Sundaram Hariharan	Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/RapamycinFungusV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "lymphoproliferative" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "lymphoproliferative" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    RapamycinFungusV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    lymphoproliferative
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Thu Nov 19 21:55:41 2020. Site generation: Thu Nov 19 22:00:39 2020